Tourmaline Bio Inc (NAS:TRML) Stock News, Headlines & Updates
Tourmaline Bio Inc Stock News from GuruFocus
- 1
May 20, 2025
Tourmaline Bio (TRML) Shares Drop After Trial Data Release
GuruFocus News • 9:58am
Tourmaline Bio Announces Positive Topline Results from the Ongoing Phase 2 TRANQUILITY Trial Evaluating Pacibekitug in Patients with Elevated High-Sensitivity C-reactive Protein and Chronic Kidney Dis
GuruFocus News • 6:47am
Tourmaline Bio (TRML) Reports Encouraging Results from Phase 2 Cardiovascular Trial | TRML Stock News
GuruFocus News • 6:46am
May 19, 2025
Tourmaline Bio to Present Topline Results from the Ongoing Phase 2 TRANQUILITY Trial of Pacibekitug on May 20, 2025
Marketwired • 4:00pm
Tourmaline Bio to Present Topline Results from the Ongoing Phase 2 TRANQUILITY Trial of Pacibekitug on May 20, 2025 | TRML Stock News
GuruFocus News • 3:15pm
May 05, 2025
HC Wainwright & Co. Reiterates Buy Rating on Tourmaline Bio (TRML) | TRML Stock News
GuruFocus News • 6:32am
Tourmaline Bio (TRML) Receives Continued 'Buy' Rating from Chardan Capital | TRML Stock News
GuruFocus News • 6:31am
May 02, 2025
Tourmaline Bio Reports First Quarter 2025 Financial Results and Recent Business Highlights
Marketwired • 7:00am
Tourmaline (TRML) Projects Financial Stability into Late 2027 | TRML Stock News
GuruFocus News • 6:47am
Tourmaline (TRML) Anticipates Key Data from Phase 2 Trial of Pacibekitug | TRML Stock News
GuruFocus News • 6:47am
Tourmaline Bio Reports First Quarter 2025 Financial Results and Recent Business Highlights | TRML Stock News
GuruFocus News • 6:47am
Apr 23, 2025
Tourmaline Bio (TRML) Receives 'Buy' Rating with Promising Drug Potential | TRML Stock News
GuruFocus News • 3:46am
Apr 10, 2025
Truist Adjusts Tourmaline Bio (TRML) Price Target Amid New Opportunities | TRML Stock News
GuruFocus News • 7:47am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news